Search results
Is There A Children's Tylenol Shortage? Here's What To Know
Parents via Yahoo News· 2 years agoHard-to-find Tylenol is making the sick season more complicated for parents and kids. Pediatricians...
Children's Advil and Tylenol shortage: What you need to know, according to experts
Yahoo Canada Style· 2 years agoThe Advil and Tylenol shortage is due to a spike in demand for children's fever and pain medication....
Maker of Tylenol, Band-Aids and Listerine holds groundbreaking for North Jersey global HQ
The Bergen Record via Yahoo Finance· 2 months agoThe maker of Tylenol, Listerine, Neutrogena, Band-Aids and Benadryl plans a global headquarters in...
Why Vertex Pharmaceuticals Stock Topped the Market Today
Motley Fool via Yahoo Finance· 4 months agoGood news from the lab sparked a mini-rally in Vertex Pharmaceuticals (NASDAQ: VRTX) stock on...
Lawsuits claiming Tylenol causes autism lack scientific support, judge finds
Reuters via Yahoo News· 6 months agoA judge has barred expert witnesses from testifying that Johnson & Johnson spin-off Kenvue's...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Motley Fool· 2 years agoTake Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that has delivered market-beating returns over the past decade. The drugmaker is still at it even...
Kenvue: A High-Quality Consumer Health Company on Sale
GuruFocus.com via Yahoo Finance· 6 months agoIn May, Kenvue Inc. (NYSE:KVUE) successfully concluded its separation from Johnson & Johnson...
ETFs to Buy on Solid Q1 JNJ Earnings Results
Zacks via Yahoo Finance· 1 year agoJohnson & Johnson JNJ set the ball rolling for the pharma and medical device manufacturer space’s first-quarter 2023 earnings on Apr 19, before the...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2023 Earnings Call Transcript April 1, 2024 NRx...
2 Best Biotech Stocks to Buy in July
Motley Fool· 11 months agoThe pharmaceutical industry can be especially lucrative for investors. Here are two giant drugmakers for income investors to consider buying this month...
